AGMASET
LIVE

Serial Number

85205611

Owner

Gilad Gad M

First Use Date

Dec 1, 2010

Filing Date

Dec 24, 2010

Add to watchlist:

No watchlists yet
View on USPTO

AGMASET Trademark

Serial Number: 85205611 • Registration: 3997624

AGMASET is a trademark filed by Gilad Gad M on December 24, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Gilad Gad M (3 trademarks)

Henderson, NV 89015

Entity Type: 01

Gilad Varda (6 trademarks)

Henderson, NV 89015

Entity Type: 01

Trademark Details

Filing Date

December 24, 2010

Registration Date

July 19, 2011

First Use Anywhere

December 1, 2010

First Use in Commerce

December 1, 2010

Published for Opposition

May 3, 2011

Goods & Services

Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Antidiabetic preparations; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary drink mix for use as a meal replacement; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for aiding nerve health; Feed supplements for pets, livestock; Food supplements; Food supplements for aiding nerve health; Foods for individuals with special dietary requirements necessitated by medical treatments; Health food supplements; Homeopathic supplements; Liquid nutritional supplement; Meal replacement and dietary supplement drink mixes; Medicated supplements for foodstuffs for animals; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for aiding nerve health; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional additives for medical purposes used in foods and dietary supplements for human consumption; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements; Nutritional supplements for aiding nerve health; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Ophthalmic preparations; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of nervous system damage; Pharmaceutical preparations for the treatment and prevention of nervous system damage; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of nervous system damage; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for nervous system damage; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Powdered nutritional supplement drink mix; Preparation for the relief of pain; Therapeutic pharmaceutical for the treatment of nervous system damage; Veterinary preparations for nervous system damage; Veterinary preparations, namely, pain relief medication; Vitamins and dietary food supplements for animals

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 13, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 13, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 13, 2021 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 20, 2020 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 19, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 28, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 28, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 28, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 24, 2016 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2016 TCCA
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 19, 2016 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 19, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2011 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2011 PUBO
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2011 CNSA
ASSIGNED TO EXAMINER
Mar 23, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2011 NWOS
NEW APPLICATION ENTERED
Dec 28, 2010 NWAP